ADVERTISEMENT

Sun Pharma Q1 Results Review - Earnings Beat Led By U.S.: Dolat Capital

Subdued India growth.

<div class="paragraphs"><p>Sun Pharma facility. (Source: Company website)</p></div>
Sun Pharma facility. (Source: Company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit